Fig. 1From: Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trialSPIRIT figure showing study’s schedule of enrolment, intervention and assessment. M0 baseline visit, M1 to M12 month 1 to month 12, qPCR quantitative polymerase chain reaction. *Safety blood tests will be performed only on treatment groupBack to article page